12:00 AM
 | 
Dec 09, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Noxafil posaconazole delayed-release tablets regulatory update

FDA approved a delayed-release tablet formulation of Noxafil posaconazole for prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >